These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 26756990)
1. Evidence of pomegranate methanolic extract in antagonizing the endogenous SERM, 27-hydroxycholesterol. Vini R; Juberiya AM; Sreeja S IUBMB Life; 2016 Feb; 68(2):116-21. PubMed ID: 26756990 [TBL] [Abstract][Full Text] [Related]
2. Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation. Sreeja S; Santhosh Kumar TR; Lakshmi BS; Sreeja S J Nutr Biochem; 2012 Jul; 23(7):725-32. PubMed ID: 21839626 [TBL] [Abstract][Full Text] [Related]
3. Pomegranate fruit as a rich source of biologically active compounds. Sreekumar S; Sithul H; Muraleedharan P; Azeez JM; Sreeharshan S Biomed Res Int; 2014; 2014():686921. PubMed ID: 24818149 [TBL] [Abstract][Full Text] [Related]
11. Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link. Asghari A; Umetani M Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650428 [TBL] [Abstract][Full Text] [Related]
12. Urolithin A: A promising selective estrogen receptor modulator and 27-hydroxycholesterol attenuator in breast cancer. Vini R; Jaikumar VS; Remadevi V; Ravindran S; Azeez JM; Sasikumar A; Sundaram S; Sreeja S Phytother Res; 2023 Oct; 37(10):4504-4521. PubMed ID: 37345359 [TBL] [Abstract][Full Text] [Related]
13. 27-Hydroxycholesterol induces invasion and migration of breast cancer cells by increasing MMP9 and generating EMT through activation of STAT-3. Shen Z; Zhu D; Liu J; Chen J; Liu Y; Hu C; Li Z; Li Y Environ Toxicol Pharmacol; 2017 Apr; 51():1-8. PubMed ID: 28257824 [TBL] [Abstract][Full Text] [Related]
14. Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort. Lu DL; Le Cornet C; Sookthai D; Johnson TS; Kaaks R; Fortner RT J Natl Cancer Inst; 2019 Apr; 111(4):365-371. PubMed ID: 30016454 [TBL] [Abstract][Full Text] [Related]
15. The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells. Zhu D; Shen Z; Liu J; Chen J; Liu Y; Hu C; Li Z; Li Y Toxicol Lett; 2016 Dec; 264():79-86. PubMed ID: 27856279 [TBL] [Abstract][Full Text] [Related]
16. Sex-opposed inflammatory effects of 27-hydroxycholesterol are mediated via differences in estrogen signaling. Houben T; Bitorina AV; Oligschlaeger Y; Jeurissen ML; Rensen S; Köhler SE; Westerterp M; Lütjohann D; Theys J; Romano A; Plat J; Shiri-Sverdlov R J Pathol; 2020 Aug; 251(4):429-439. PubMed ID: 32472585 [TBL] [Abstract][Full Text] [Related]
17. Obesity, cholesterol metabolism, and breast cancer pathogenesis. McDonnell DP; Park S; Goulet MT; Jasper J; Wardell SE; Chang CY; Norris JD; Guyton JR; Nelson ER Cancer Res; 2014 Sep; 74(18):4976-82. PubMed ID: 25060521 [TBL] [Abstract][Full Text] [Related]
18. Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines. Kim J; Lee J; Jang SY; Kim C; Choi Y; Kim A Oncol Rep; 2016 May; 35(5):2553-60. PubMed ID: 26986571 [TBL] [Abstract][Full Text] [Related]
19. Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells. Shah YM; Al-Dhaheri M; Dong Y; Ip C; Jones FE; Rowan BG Mol Cancer Ther; 2005 Aug; 4(8):1239-49. PubMed ID: 16093440 [TBL] [Abstract][Full Text] [Related]
20. Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial. Going CC; Alexandrova L; Lau K; Yeh CY; Feldman D; Pitteri SJ Breast Cancer Res Treat; 2018 Feb; 167(3):797-802. PubMed ID: 29116467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]